Publicaciones en colaboración con investigadores/as de Centro de Investigaciones Biológicas (22)

2024

  1. Circulating immunome fingerprint in eosinophilic esophagitis is associated with clinical response to proton pump inhibitor treatment

    Frontiers in Immunology, Vol. 15

2022

  1. Functional Alterations Involved in Increased Bleeding in Hereditary Hemorrhagic Telangiectasia Mouse Models

    Frontiers in Medicine, Vol. 9

  2. Straightening the crooked: Intraspecific divergence of stem posture control and associated trade-offs in a model conifer

    Journal of Experimental Botany, Vol. 73, Núm. 4, pp. 1222-1235

  3. Whole blood DNA methylation analysis reveals respiratory environmental traits involved in COVID-19 severity following SARS-CoV-2 infection

    Nature Communications, Vol. 13, Núm. 1

2017

  1. Eculizumab in secondary atypical haemolytic uraemic syndrome

    Nephrology Dialysis Transplantation, Vol. 32, Núm. 3, pp. 466-474

  2. The role of endoglin in post-ischemic revascularization

    Angiogenesis, Vol. 20, Núm. 1

2016

  1. Molecular basis of factor H R1210C association with ocular and renal diseases

    Journal of the American Society of Nephrology, Vol. 27, Núm. 5, pp. 1305-1311

2015

  1. Performance of rodent spermatozoa over time is enhanced by increased ATP concentrations: The role of sperm competition

    Biology of Reproduction, Vol. 93, Núm. 3

2013

  1. In vitro and in vivo effects of an anti-mouse endoglin (CD105)-immunotoxin on the early stages of mouse B16MEL4A5 melanoma tumours

    Cancer Immunology, Immunotherapy, Vol. 62, Núm. 3, pp. 541-551

2012

  1. Local sclerotherapy with polydocanol (Aethoxysklerol®) for the treatment of epistaxis in Rendu-Osler-Weber or hereditary hemorrhagic telangiectasia (HHT): 15 years of experience

    Rhinology, Vol. 50, Núm. 1, pp. 80-86

  2. Transient injury-dependent up-regulation of CD105 and its specific targeting with an anti-vascular anti-mouse endoglin-nigrin b immunotoxin

    Medicinal Chemistry, Vol. 8, Núm. 6, pp. 996-1002

2010

  1. Comparative efficacy of novobiocin and amoxicillin in experimental sepsis caused by β-lactam-susceptible and highly resistant pneumococci

    International Journal of Antimicrobial Agents, Vol. 35, Núm. 6, pp. 544-549

2007

  1. In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains

    Journal of Antimicrobial Chemotherapy, Vol. 60, Núm. 5, pp. 1159-1162

  2. Pneumococcal LytA autolysin, a potent therapeutic agent in experimental peritonitis-sepsis caused by highly β-lactam-resistant Streptococcus pneumoniae

    Antimicrobial Agents and Chemotherapy, Vol. 51, Núm. 9, pp. 3371-3373

  3. Targeting a marker of the tumour neovasculature using a novel anti-human CD105-immunotoxin containing the non-toxic type 2 ribosome-inactivating protein nigrin b

    Cancer Letters, Vol. 256, Núm. 1, pp. 73-80

2006

  1. A CXCL2 tandem repeat promoter polymorphism is associated with susceptibility to severe sepsis in the Spanish population

    Genes and Immunity, Vol. 7, Núm. 2, pp. 141-149

1996

  1. Transient inhibition of capacitative calcium entry in human neutrophils by a monoclonal antibody directed against a 19-kDa antigen

    Journal of Leukocyte Biology, Vol. 60, Núm. 3, pp. 323-327

1992

  1. Low temperature thermal behaviour of chitins and chitin-glucans

    Thermochimica Acta, Vol. 211, Núm. C, pp. 241-254

1991

  1. The role of intracellular acidification in calcium mobilization in human neutrophils

    BBA - Molecular Cell Research, Vol. 1093, Núm. 1

  2. Thermolytical Techniques To Characterize Fungal Polysaccharides and Bacterial Lipopolysaccharides

    Biotechnology Progress, Vol. 7, Núm. 6, pp. 526-533